A Spatial Agent-Based Model of AGE-RAGE Feedback in Hepatic Fibrosis Reveals Stage-Dependent Irreversibility Thresholds
Abstract
Hepatic fibrosis progression involves a well-characterized but computationally unmodeled feedback loop: Advanced Glycation End-products (AGEs) accumulate on permanent collagen via Maillard chemistry, activate the Receptor for Advanced Glycation End-products (RAGE) on hepatic stellate cells (HSCs) and Kupffer cells, drive NF-{kappa}B-mediated HSC activation and anti-apoptotic signaling, and deplete soluble RAGE (sRAGE) through hepatocyte loss -- creating a closed positive feedback loop. To our knowledge, we present the first spatial agent-based model incorporating the complete AGE-RAGE-sRAGE axis in a three-dimensional GPU-accelerated liver tissue simulation. The model produces three key findings: (i) stage-dependent irreversibility thresholds emerge without explicit stage-gating, with resolution declining from [~]68% at F2 to <10% at F4; (ii) sRAGE trajectories diverge at F2-F3: recovering during abstinence from F2 (0.68 [->] 0.87) but remaining depleted from F3 (0.54), predicting a clinically testable biomarker transition; and (iii) RAGE-driven HSC activation becomes self-sustaining at F3+ independent of exogenous injury, explaining why late-stage fibrosis resists resolution despite removal of the primary insult. No prior computational model -- ODE, PDE, or agent-based -- has formalized the complete RAGE-AGE-sRAGE feedback loop in hepatic fibrosis. The sRAGE divergence prediction is independently testable in clinical cohorts.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A rule-based multiscale model of hepatic stellate cell plasticity: critical role of the inactivation loop in fibrosis progression
Matthieu Bouguéon, Vincent Legagneux, … Nathalie Théret·PLoS Computational BiologyPeer-reviewed·Jul 29, 2024
- Amniotic Fluid Reduces Liver Fibrosis By Attenuating Hepatic Stellate Cell Activation
Charles M. Bowen, Frederick S. Ditmars, … William Samuel Fagg·Stem Cells Translational MedicinePeer-reviewed·May 30, 2025
- Hepatocyte FGFR2 Mediates the Antifibrotic Effects of FGF10 in Advanced Liver Fibrosis.
Xuanxin Yang, Bingjie Yu, … Xiaojie Wang·bioRxiv·Nov 18, 2025
- The hepatocyte Epidermal Growth Factor Receptor (EGFR) pathway regulates the cellular interactome within the liver fibrotic niche
E. Gonzalez-Sanchez, J. Vaquero, … I. Fabregat·bioRxiv·Nov 3, 2023
- Intercellular crosstalk regulating ARRB2/RARRES1 is involved in transition from fibrosis to cancer
Robert Schierwagen, Peter Dietrich, … Jonel Trebicka·bioRxiv·Sep 8, 2021
- The interplay between biomechanics and cell kinetics explains the spatial pattern in liver fibrosis
Jieling Zhao, Seddik Hammad, … Dirk Drasdo·bioRxiv·Jul 31, 2025